- Home
- Life Sciences
- Pharmaceutical
- Drug Discovery and Development
- Drug Discovery and Development Analysis & Statistics, June 2013
Talk to Alexandra
(866) 682 9815
Search inside this page
Top countries
Publishers
- All
- GBI Research
data types
Free Market Research Guides to Download
Drug Discovery and Development Analysis & Statistics, June 2013
You might be interested in: clinical trial, drug discovery, drug development, more »
» Purchase Premium Reports
1-30 of 40 reports
Biomarkers in Drug Discovery - Integration in Early Stage Promotes Use of Companion Diagnostics to Optimize Therapeutic Outcomes
- $ 3 500
- Industry report
- November 2012
- by GBI Research
Biomarkers in Drug Discovery - Integration in Early Stage Promotes Use of Companion Diagnostics to Optimize Therapeutic Outcomes Summary GBI Research's new report, ?Biomarkers in Drug Discovery - Integration ...
- Industries : Drug Discovery and Development
- Countries : World
Drug Discovery and Development Market in Asia - Partnerships Between MNCs and Asian Academic Institutions and Healthcare Research Organizations are Driving R&D Innovation
- $ 3 500
- Industry report
- November 2012
- by GBI Research
Drug Discovery and Development Market in Asia - Partnerships Between MNCs and Asian Academic Institutions and Healthcare Research Organizations are Driving R&D Innovation Summary GBI Research, a leading ...
- Industries : Drug Discovery and Development
- Countries : Asia
Engaging Key Opinion Leaders (KOLs) - Identifying and Leveraging New KOL Groups to Drive Medical Marketing Strategy
- $ 3 500
- Industry report
- September 2012
- by GBI Research
Engaging Key Opinion Leaders (KOLs) - Identifying and Leveraging New KOL Groups to Drive Medical Marketing Strategy Summary GBI Research, the leading business intelligence provider, has released its ...
- Industries : Drug Discovery and Development
- Countries : United States
Pathways to Efficient Drug Development - Advances in Modeling and Simulation Outcomes to Fuel Pipeline Productivity
- $ 3 500
- Industry report
- September 2012
- by GBI Research
Pathways to Efficient Drug Development - Advances in Modeling and Simulation Outcomes to Fuel Pipeline Productivity Summary GBI Research, the leading business intelligence provider, has released its ...
- Industries : Drug Discovery and Development
- Countries : United States
Accelerating Drugs to Market - Despite Challenges, Adaptive Clinical Trials Reduce Drug Development Costs and Time to Market
- $ 3 500
- Industry report
- September 2012
- by GBI Research
Accelerating Drugs to Market - Despite Challenges, Adaptive Clinical Trials Reduce Drug Development Costs and Time to Market Summary GBI Research's new report, ?Accelerating Drugs to Market - Despite ...
- Industries : Drug Discovery and Development
Clinical Supply Chain Management - Technologies such as IVRS, CTMS, EDC and RFID Enhance Drug Supply Management
- $ 3 500
- Industry report
- August 2012
- by GBI Research
Clinical Supply Chain Management - Technologies such as IVRS, CTMS, EDC and RFID Enhance Drug Supply Management Summary GBI Research, leading business intelligence provider has released its latest research ...
- Industries : Drug Discovery and Development
- Countries : India, China, World
e-Clinical Trial Solutions Market to 2018 - Growing Complexity of Clinical Trials and Increased Focus on Accuracy and Efficiency Drive Trial Sponsors to Adopt Novel Technologies
- $ 3 500
- Industry report
- July 2012
- by GBI Research
e-Clinical Trial Solutions Market to 2018 - Growing Complexity of Clinical Trials and Increased Focus on Accuracy and Efficiency Drive Trial Sponsors to Adopt Novel Technologies Summary GBI Research, ...
- Industries : Drug Discovery and Development
- Countries : World
Protein and Peptide-based Therapeutics - Trends in Drug Discovery and Development
- $ 3 500
- Industry report
- July 2012
- by GBI Research
Summary GBI Research, leading business intelligence provider, has released its latest research report, entitled ?Protein and Peptide-based Therapeutics - Trends in Drug Discovery and Development". Ove ...
- Industries : Drug Discovery and Development
Endpoints - Clinical Trials in Respiratory Diseases - Pulmonary Function Tests, Biomarkers and Quality of Life Questionnaires All Play Prominent Roles
- $ 3 500
- Industry report
- June 2012
- by GBI Research
Endpoints - Clinical Trials in Respiratory Diseases - Pulmonary Function Tests, Biomarkers and Quality of Life Questionnaires All Play Prominent Roles Summary GBI Research in its report ?Endpoints - ...
- Industries : Drug Discovery and Development
- Countries : World
Emerging Pharmaceutical Market in Argentina - Domestic Pharmaceutical Companies Dominate the Market with More Than 55% of the Industry Revenue
- $ 3 500
- Industry report
- June 2012
- by GBI Research
Emerging Pharmaceutical Market in Argentina - Domestic Pharmaceutical Companies Dominate the Market with More Than 55% of the Industry Revenue Summary GBI Research's new report, ?Emerging Pharmaceutical ...
- Industries : Drug Discovery and Development
- Countries : Argentina
Workforce Reductions in Pharmaceuticals - Outsourcing, External Innovation and Collaboration Will Drive the Industry Forward
- $ 3 500
- Industry report
- June 2012
- by GBI Research
Workforce Reductions in Pharmaceuticals - Outsourcing, External Innovation and Collaboration Will Drive the Industry Forward Summary GBI Research, the leading business intelligence provider, has released ...
- Industries : Drug Discovery and Development
- Countries : United States
Patient Perspectives - Patient Reported Outcomes Drive Drug Development, but Improving Patient Involvement Remains a Challenge
- $ 3 500
- Industry report
- May 2012
- by GBI Research
Patient Perspectives - Patient Reported Outcomes Drive Drug Development, but Improving Patient Involvement Remains a Challenge Summary GBI Research, the leading business intelligence provider, has released ...
- Industries : Drug Discovery and Development
- Countries : United States
Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs
- $ 3 500
- Industry report
- April 2012
- by GBI Research
Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs Summary GBI Research, the leading business ...
- Industries : Drug Discovery and Development
- Countries : World, India
Endpoints - Clinical Trials in Cardiovascular Disorders - Optimal Use of Surrogate Endpoints and Clinical Biomarkers are Key Determinants of Success
- $ 3 500
- Industry report
- January 2012
- by GBI Research
Endpoints - Clinical Trials in Cardiovascular Disorders - Optimal Use of Surrogate Endpoints and Clinical Biomarkers are Key Determinants of Success Summary GBI Research, the leading business intelligence ...
- Industries : Drug Discovery and Development
- Countries : World
Endpoints - Clinical Trials in Dermatology - Inflammatory Lesions Count is the Key Determinant of Success in Acne Vulgaris Clinical Trials
- $ 3 500
- Industry report
- January 2012
- by GBI Research
Endpoints - Clinical Trials in Dermatology - Inflammatory Lesions Count is the Key Determinant of Success in Acne Vulgaris Clinical Trials Summary GBI Research, the leading business intelligence provider, ...
- Industries : Drug Discovery and Development
- Countries : World
Emerging Market for Clinical Trials in Poland - Cost Advantages of Nearly 30% as Compared to the US
- $ 3 500
- Industry report
- December 2011
- by GBI Research
Emerging Market for Clinical Trials in Poland - Cost Advantages of Nearly 30% as Compared to the US Summary GBI Research, the leading business intelligence provider, has released its latest report, ?Emerging ...
- Industries : Drug Discovery and Development
- Countries : Poland
Endpoints - Clinical Trials in CNS Disorders - Multiple Endpoints and Ratings Scales are Becoming More Widely Adopted
- $ 3 500
- Industry report
- November 2011
- by GBI Research
Endpoints - Clinical Trials in CNS Disorders - Multiple Endpoints and Ratings Scales are Becoming More Widely Adopted Summary GBI Research, the leading business intelligence provider, has released its ...
- Industries : Drug Discovery and Development
- Countries : World
Biomarkers in Drug Discovery - Earlier Usage of Biomarkers in Optimization Stage to Reduce Drug Attrition Rate Significantly
- $ 3 500
- Industry report
- October 2011
- by GBI Research
Biomarkers in Drug Discovery - Earlier Usage of Biomarkers in Optimization Stage to Reduce Drug Attrition Rate Significantly Summary GBI Research, the leading business intelligence provider, has released ...
- Industries : Drug Discovery and Development
- Countries : World
Post Marketing Clinical Research - REMS, the Latest Reformation due to Post Marketing Surveillance to Enhance Patient Compliance
- $ 3 500
- Industry report
- September 2011
- by GBI Research
Post Marketing Clinical Research - REMS, the Latest Reformation due to Post Marketing Surveillance to Enhance Patient Compliance Summary GBI Research has released its latest report, ?Post Marketing Clinical ...
- Industries : Drug Discovery and Development
- Countries : United States, Japan, Europe, World
Clinical Trial Recruitment in Cardiovascular Diseases - Average Patient Recruitment per Trial was the Highest in Venous Thromboembolism
- $ 3 500
- Industry report
- September 2011
- by GBI Research
Clinical Trial Recruitment in Cardiovascular Diseases - Average Patient Recruitment per Trial was the Highest in Venous Thromboembolism Summary GBI Research, the leading business intelligence provider, ...
- Industries : Drug Discovery and Development
- Countries : Brazil, India, China, World
Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets
- $ 3 500
- Industry report
- September 2011
- by GBI Research
Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets Summary GBI ...
- Industries : Drug Discovery and Development
- Countries : India, China
Pharmaceutical Partnership Deal Terminations
- $ 3 500
- Industry report
- September 2011
- by GBI Research
Pharmaceutical Partnership Deal Terminations Summary GBI Research, the leading business intelligence provider, has released its latest report, ?Pharmaceutical Partnership Deal Terminations? which provides ...
- Industries : Drug Discovery and Development
Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force
- $ 3 500
- Industry report
- August 2011
- by GBI Research
Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force Summary GBI Research's report, ?Emerging Pharmaceutical ...
- Industries : Drug Discovery and Development
- Countries : India
Top R&D Drug Failures - Toxicity and Serious Adverse Events in Late Stage Drug Development are the Major Causes of Drug Failure
- $ 3 500
- Industry report
- July 2011
- by GBI Research
Top R&D Drug Failures - Toxicity and Serious Adverse Events in Late Stage Drug Development are the Major Causes of Drug Failure Summary GBI Research, leading business intelligence provider, has released ...
- Industries : Drug Discovery and Development
Emerging Market for Clinical Trials in Brazil - Improved Guidelines from ANVISA and CONEP are Shortening the Regulatory Approval Process and Advancing the Market
- $ 3 500
- Industry report
- July 2011
- by GBI Research
Emerging Market for Clinical Trials in Brazil - Improved Guidelines from ANVISA and CONEP are Shortening the Regulatory Approval Process and Advancing the Market Summary GBI Research, the leading business ...
- Industries : Drug Discovery and Development
- Countries : Brazil
Emerging Market for Clinical Trials in Russia - Curbs on New Drug Approval Timelines and Registration Fees Encourage the Emergence of a Major Global Player
- $ 3 500
- Industry report
- July 2011
- by GBI Research
Emerging Market for Clinical Trials in Russia - Curbs on New Drug Approval Timelines and Registration Fees Encourage the Emergence of a Major Global Player Summary GBI Research has released its latest ...
- Industries : Drug Discovery and Development
- Countries : Russian Federation
Emerging Market for Clinical Trials in Argentina - Major Cost Advantages over the US in Conducting Clinical Trials Will Encourage Drug Development
- $ 3 500
- Industry report
- July 2011
- by GBI Research
Emerging Market for Clinical Trials in Argentina - Major Cost Advantages over the US in Conducting Clinical Trials Will Encourage Drug Development Summary GBI Research has released its latest report, ?Emerging ...
- Industries : Drug Discovery and Development
- Countries : Argentina
Lead Generation Strategies and Technologies in Drug Development - Emerging Techniques Such as Antisense Technology Will Allow Innovators to Minimize Costs
- $ 3 500
- Industry report
- June 2011
- by GBI Research
Lead Generation Strategies and Technologies in Drug Development - Emerging Techniques Such as Antisense Technology Will Allow Innovators to Minimize Costs Summary GBI Research has released its latest report, ...
- Industries : Drug Discovery and Development
Time and Cost Reduction in Clinical Trials- Outsourcing and IT to Optimize Patient Recruitment, Logistics, Data and Site Management
- $ 3 500
- Industry report
- June 2011
- by GBI Research
Time and Cost Reduction in Clinical Trials- Outsourcing and IT to Optimize Patient Recruitment, Logistics, Data and Site Management Summary GBI Research, the leading business intelligence provider, has ...
- Industries : Drug Discovery and Development
- Countries : India
Lifesciences IT - 2011 Yearbook
- $ 3 500
- Industry report
- June 2011
- by GBI Research
Lifesciences IT - 2011 Yearbook Summary GBI Research's research, ?Lifesciences IT - 2011 Yearbook" provides key data, information and analysis on Lifesciences \IT that is being implemented by pharmaceutical ...
- Industries : Drug Discovery and Development
- Countries : United States, India, World
» Download Public Reports
About 3 000 reports
Company Report: Drug Discovery in France and Germany for Year 2013
- Company report
- April 2013
- 2 pages
... Health will drive forward public health knowledge, which is a key issue for all governments." The french-german advanced translational drug discovery center is a unique project of public- private ...
Reportlinker.com © Copyright 2013. All rights reserved.
